Author
Listed:
- Ioana-Marcela PÄ‚CURARU
(Bucharest University of Economic Studies, Bucharest, Romania)
- Ciprian-Sorin CHIRVASE
(Bucharest University of Economic Studies, Bucharest, Romania)
- Åžtefan-Ioan TIRITEU
(Bucharest University of Economic Studies, Bucharest, Romania)
Abstract
Artificial Intelligence (AI) has emerged as a transformative technology in healthcare, significantly advancing personalised medicine. By leveraging vast amounts of data, AI enhances early disease detection, tailors treatments to individual patients, and optimises medical resource management. Despite these advantages, the integration of AI in healthcare presents challenges, including concerns over data privacy, acceptance among healthcare professionals, and the need for comprehensive regulatory frameworks. Therefore, this study investigates the impact of AI on personalised medicine, assessing its benefits, limitations, and real-world applications. It explores AI’s role in diagnostics, personalised treatment strategies, and the optimisation of medical workflows, while critically examining ethical and legal challenges. The study also underscores the necessity of robust regulations to ensure responsible and ethical AI deployment in healthcare. A systematic documentary analysis of scientific articles, case studies, and healthcare organisation reports forms the basis of this research. Case studies from hospitals and companies that have successfully implemented AI are analysed to evaluate its impact on diagnostic accuracy, treatment efficiency, and medical costs. The findings are correlated with existing literature to provide a comprehensive perspective on current and future trends in AI-driven personalised medicine. The results of this study show that AI has demonstrated significant improvements in diagnostic precision, reduced the time required for disease identification, and enhanced the effectiveness of personalised treatment plans. Studies indicate that AI-driven approaches contribute to cost reductions by minimising late-stage treatments and enabling more efficient allocation of medical resources. However, critical challenges such as algorithm transparency, bias mitigation, and patient data security continue to hinder widespread AI adoption in healthcare.
Suggested Citation
Ioana-Marcela PÄ‚CURARU & Ciprian-Sorin CHIRVASE & Åžtefan-Ioan TIRITEU, 2025.
"The Role Of Artificial Intelligence In Personalised Medicine: Advancements, Challenges, And Future Perspectives,"
Business Excellence and Management, Faculty of Management, Academy of Economic Studies, Bucharest, Romania, vol. 15(1), pages 59-84, March.
Handle:
RePEc:rom:bemann:v:15:y:2025:i:1:p:59-84
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:rom:bemann:v:15:y:2025:i:1:p:59-84. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Zamfir Andreea (email available below). General contact details of provider: https://edirc.repec.org/data/mnasero.html .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.